Skip to Content

MainStay WMC Value A MAPAX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 28.17  /  −0.46 %
  • Total Assets 974.6 Mil
  • Adj. Expense Ratio
    1.020%
  • Expense Ratio 1.020%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 15,000
  • Status Open
  • TTM Yield 1.40%
  • Turnover 29%

USD | NAV as of Feb 26, 2024 | 1-Day Return as of Feb 26, 2024, 11:11 PM GMT+0

Morningstar’s Analysis MAPAX

Will MAPAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A drop in its Process Pillar rating is the primary driver of MainStay WMC Value A's downgrade to a Morningstar Medalist Rating of Negative from Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MAPAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

3.88 37.3 Mil
Financial Services

Johnson & Johnson

2.94 28.3 Mil
Healthcare

Merck & Co Inc

2.69 25.9 Mil
Healthcare

Cisco Systems Inc

2.54 24.4 Mil
Technology

Pfizer Inc

2.28 21.9 Mil
Healthcare

ConocoPhillips

2.06 19.8 Mil
Energy

Elevance Health Inc

1.92 18.5 Mil
Healthcare

PNC Financial Services Group Inc

1.92 18.5 Mil
Financial Services

M&T Bank Corp

1.91 18.3 Mil
Financial Services

Centene Corp

1.78 17.1 Mil
Healthcare